Abstract:
Objective : To investigate the effects of bFGF and celecoxib on proliferation, apoptosis and expression of COX-2, NF-kB, and VEGF protein in BGC-823 gastric carcinoma cells.
Methods : BGC-823 gastric carcinoma cells were treated with bFGF and celecoxib. Proliferation, apoptosis, mor-phology and expression of COX-2, NF-kB, and VEGF protein were observed using MTT, flow cytome-try, fluorescence microscopy and Western blotting, respectively.
Results : bFGF promoted BGC-823 cell proliferation and expression of COX-2, NF-kB and VEGF protein at a concentration of 25 ng/ml in a time-dependent manner (尸<0.01). Celecoxib at different concentrations inhibited proliferation of BGC- 823 cells and induced apoptosis. The expression of COX-2, NF-kB and VEGF protein was attenuated in a dose-dependent manner (P<0.01).
Conclusion : bFGF can promote BGC-823 cell proliferation and expression of COX-2,NF-kB, and VEGF protein. Celecoxib promotes apoptosis of BGC-823 cells and inhibits expression of COX-2, NF-kB and VEGF protein in a dose-dependent manner. COX-2, NF- kB and VEGF show interaction during the progression of carcinoma (r=0.852, 0.908 and 0.930,respec-tively; P<0.01).